• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
SCPS

SCPS

Scopus BioPharma Inc.

OTCHealthcareBiotechnologyUS

USD0.00

+0.00 (+50.00%)

Company Profile

CEO

Alan D. Horsager

IPO Date

2020-12-16

Sector

Healthcare

Industry

Biotechnology

Exchange

OTC

Country

US

Market Metrics

Open

$0.00

Prev. Close

$0.00

Day Low

$0.00

Day High

$0.00

52W Low

$0.00

52W High

$0.01

Market Cap

$0.00B

Volume

0.05M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

37.5%

Avg Negative

7.0%

Avg Neutral

55.4%

News Feed

Scopus BioPharma Announces New Management Appointment Following Acquisition of Leading Immunotherapy Company

GlobeNewsWire·7/12/2021·↑ positive

Scopus BioPharma Announces New Date for 2021 Annual Meeting of Stockholders

GlobeNewsWire·5/31/2021·↓ negative

Scopus BioPharma to Reschedule 2021 Annual Meeting of Shareholders

GlobeNewsWire
·5/26/2021
·↓ negative

SCPS Stock Price: 71.98% Increase Explanation

Pulse2·5/25/2021·↑ positive

Why Scopus BioPharma's Stock Is Surging Today

Benzinga·5/24/2021·↑ positive

Why Scopus BioPharma Stock More Than Double Today?

Benzinga·5/24/2021·↑ positive

Here's why Scopus BioPharma gained 200% on Monday

Invezz·5/24/2021·↑ positive

SCPS Stock Price: Over 200% Increase Explanation

Pulse2·5/24/2021·↑ positive

Scopus BioPharma Announces FDA Approval of IND Application for Lead Drug Candidate

GlobeNewsWire·5/24/2021·↑ positive

Scopus BioPharma Announces Closing of Underwriters' Over-Allotment Option in Full

PRNewsWire·2/10/2021·↑ positive